InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Carter Erin Catherine. Officer active across 1 company, notably GlucoTrack, Inc.. Cumulatively, 4 disclosures have been recorded. History available since 31 December 2023. The latest transaction was disclosed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Carter Erin Catherine is a declarant and a Director of GlucoTrack, Inc. on XNAS. She has 4 filings in total, and the 4 sampled filings run from 2025-03-31 to 2025-10-07, with buy and sell amounts of EUR 0 and a modal transaction nature of Attribution.